Five renowned researchers to guide febit's research and business
MEDFORD, Mass. and HEIDELBERG, Germany, March 31 /PRNewswire/ -- febit
group, the provider of the unique microfluidic microarray system Geniom,
today announced the formation of a Scientific Advisory Board (SAB)
consisting of leading authorities at the forefront of genetics and genomics
research. The SAB members, from top research institutions and companies,
will provide expert advice on febit's research and development activities
associated with its portfolio development.
The interdisciplinary febit Scientific Advisory Board consists of:
-- Mark Chee, Ph.D., who will serve as chairman. As a former scientist of
Affymetrix and co-founder of Illumina (ILMN) he has an exceptional
knowledge of microarray technologies and market.
-- Karoly Nikolich, Ph.D., who will serve as vice chairman. Dr. Nikolich
was formerly the executive director of the Neuroscience Institute of
Stanford. He is an entrepreneur and consultant, and has over 20 years
of biotechnology industry experience in R&D.
-- David Lockhart, Ph.D., the CSO of Amicus Therapeutics. Dr. Lockhart
brings many years of industry experience and achievements, including
credit as the primary inventor and developer of genome-wide
gene-expression profiling with high-density DNA arrays when he was at
-- Mostafa Ronaghi, Ph.D., one of the inventors of Pyrosequencing,
molecular inversion probe assay and Nextbio search engine. He has
co-founded four companies and serves on the board of director and
scientific advisory board of several companies.
-- Jeffrey Trent, Ph.D., the president and scientific director of the
Translational Genomics Research Institute (TGen) in Phoenix, Ariz. In
addition to his expertise in cDNA-mic
|Copyright©2008 PR Newswire.|
All rights reserved